Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,457,632
+$415,743 QoQ
Shares Held
2,049
-7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#2,308
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2024CallValue
$354,376
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026D'Orazio & Associates, Inc. holds $10,937,903 across 10 Drug Manufacturers - General names. LLY ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,747 | $2,475,445 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,049 | $2,457,632 | |
| 3 | ABBV |
AbbVie Inc.
|
5,514 | $1,387,542 | |
| 4 | AMGN |
Amgen Inc
|
3,096 | $1,121,123 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
7,176 | $906,615 | |
| 6 | NVS |
Novartis AG
|
4,370 | $684,866 | |
| 7 | PFE |
Pfizer Inc
|
24,083 | $579,918 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,050 | $520,425 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,457,632 | 2,049 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,041,889 | 2,220 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,212,766 | 2,059 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,366,533 | 1,791 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,546,587 | 1,984 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,660,079 | 2,010 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,492,276 | 1,933 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,763,906 | 1,991 | Shares | Sole | 2024-11-05 | |
| 2024-09-30 | $354,376 | 400 | Call | Sole | 2024-11-05 | |
| 2024-06-30 | $1,793,557 | 1,981 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,506,130 | 1,936 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,100,552 | 1,888 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $984,559 | 1,833 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $751,774 | 1,603 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $757,927 | 2,207 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,047,765 | 2,864 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $812,255 | 2,512 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $667,913 | 2,060 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $398,627 | 1,392 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $254,122 | 920 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $173,749 | 752 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $147,810 | 644 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $132,268 | 708 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $119,369 | 707 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $104,502 | 706 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $115,746 | 705 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $97,658 | 704 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||